| Product NDC: | 52544-284 |
| Proprietary Name: | Crinone |
| Non Proprietary Name: | progesterone |
| Active Ingredient(s): | 90 mg/1.125g & nbsp; progesterone |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52544-284 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020701 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970513 |
| Package NDC: | 52544-284-02 |
| Package Description: | 2 APPLICATOR in 1 CARTON (52544-284-02) > 1.125 g in 1 APPLICATOR |
| NDC Code | 52544-284-02 |
| Proprietary Name | Crinone |
| Package Description | 2 APPLICATOR in 1 CARTON (52544-284-02) > 1.125 g in 1 APPLICATOR |
| Product NDC | 52544-284 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | progesterone |
| Dosage Form Name | GEL |
| Route Name | VAGINAL |
| Start Marketing Date | 19970513 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | PROGESTERONE |
| Strength Number | 90 |
| Strength Unit | mg/1.125g |
| Pharmaceutical Classes | Progesterone [Chemical/Ingredient],Progesterone [EPC] |